Загрузка...
CRIM-negative infantile Pompe disease: Characterization of immune responses in patients treated with ERT monotherapy
PURPOSE: Enzyme replacement therapy (ERT) with recombinant human GAA (rhGAA) prolongs survival in infantile Pompe disease (IPD). However, the majority of cross reactive immunologic material (CRIM)-negative (CN) patients have immune responses with significant clinical decline despite continued ERT. W...
Сохранить в:
Опубликовано в: : | Genet Med |
---|---|
Главные авторы: | , , , , , , , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
2015
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4561024/ https://ncbi.nlm.nih.gov/pubmed/25741864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2015.6 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|